BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hunter AC, Elsom J, Wibroe PP, Moghimi SM. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. Nanomedicine 2012;8 Suppl 1:S5-20. [PMID: 22846372 DOI: 10.1016/j.nano.2012.07.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Park CG, Huh BK, Kim S, Lee SH, Hong HR, Choy YB. Nanostructured mucoadhesive microparticles to enhance oral drug bioavailability. Journal of Industrial and Engineering Chemistry 2017;54:262-9. [DOI: 10.1016/j.jiec.2017.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
2 Martins JT, Ramos ÓL, Pinheiro AC, Bourbon AI, Silva HD, Rivera MC, Cerqueira MA, Pastrana L, Malcata FX, González-fernández Á, Vicente AA. Edible Bio-Based Nanostructures: Delivery, Absorption and Potential Toxicity. Food Eng Rev 2015;7:491-513. [DOI: 10.1007/s12393-015-9116-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
3 Hong L, Chen L, Ladika M, Li Y, Kim-habermehl L, Bergman R. Impact of particle size and surface charge density on redispersibility of spray-dried powders. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2014;459:274-81. [DOI: 10.1016/j.colsurfa.2014.07.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Fröhlich E, Roblegg E. Mucus as Physiological Barrier to Intracellular Delivery. In: Prokop A, Iwasaki Y, Harada A, editors. Intracellular Delivery II. Dordrecht: Springer Netherlands; 2014. pp. 139-63. [DOI: 10.1007/978-94-017-8896-0_7] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
5 Debotton N, Dahan A. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms: POLYMERS AS PHARMACEUTICAL EXCIPIENTS. Med Res Rev 2017;37:52-97. [DOI: 10.1002/med.21403] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
6 Ding X, Janjanam J, Tiwari A, Thompson M, Heiden PA. Peptide-directed self-assembly of functionalized polymeric nanoparticles part I: design and self-assembly of peptide-copolymer conjugates into nanoparticle fibers and 3D scaffolds. Macromol Biosci 2014;14:853-71. [PMID: 24610743 DOI: 10.1002/mabi.201300569] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
7 Ravi PR, Vats R, Balija J, Adapa SPN, Aditya N. Modified pullulan nanoparticles for oral delivery of lopinavir: Formulation and pharmacokinetic evaluation. Carbohydrate Polymers 2014;110:320-8. [DOI: 10.1016/j.carbpol.2014.03.099] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
8 He H, Xie Y, Lv Y, Qi J, Dong X, Zhao W, Wu W, Lu Y. Bioimaging of Intact Polycaprolactone Nanoparticles Using Aggregation-Caused Quenching Probes: Size-Dependent Translocation via Oral Delivery. Adv Healthc Mater 2018;7:e1800711. [PMID: 30345713 DOI: 10.1002/adhm.201800711] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
9 Polat H, Kutluay G, Polat M. Analysis of dilution induced disintegration of micellar drug carriers in the presence of inter and intra micellar species. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2020;601:124989. [DOI: 10.1016/j.colsurfa.2020.124989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
10 de Sá Coutinho D, Pires J, Gomes H, Raffin Pohlmann A, Stanisçuaski Guterres S, Rodrigues E Silva PM, Martins MA, Ferrarini SR, Bernardi A. Pequi (Caryocar brasiliense Cambess)-Loaded Nanoemulsion, Orally Delivered, Modulates Inflammation in LPS-Induced Acute Lung Injury in Mice. Pharmaceutics 2020;12:E1075. [PMID: 33187057 DOI: 10.3390/pharmaceutics12111075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Hasnain MS, Nayak AK, Kurakula M, Hoda MN. Alginate nanoparticles in drug delivery. Alginates in Drug Delivery. Elsevier; 2020. pp. 129-52. [DOI: 10.1016/b978-0-12-817640-5.00006-6] [Cited by in Crossref: 8] [Article Influence: 4.0] [Reference Citation Analysis]
12 Ishak K, Mohamad Annuar M, Ahmad N. Nano-delivery Systems for Nutraceutical Application. Nanotechnology Applications in Food. Elsevier; 2017. pp. 179-202. [DOI: 10.1016/b978-0-12-811942-6.00009-1] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Cosco D, Paolino D, De Angelis F, Cilurzo F, Celia C, Di Marzio L, Russo D, Tsapis N, Fattal E, Fresta M. Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response. European Journal of Pharmaceutics and Biopharmaceutics 2015;89:30-9. [DOI: 10.1016/j.ejpb.2014.11.012] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 7.1] [Reference Citation Analysis]
14 Rees M, Moghimi SM. Nanotechnology: from fundamental concepts to clinical applications for healthy aging. Nanomedicine: Nanotechnology, Biology and Medicine 2012;8:S1-4. [DOI: 10.1016/j.nano.2012.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
15 Omari-Siaw E, Zhu Y, Wang H, Peng W, Firempong CK, Wang YW, Cao X, Deng W, Yu J, Xu X. Hypolipidemic potential of perillaldehyde-loaded self-nanoemulsifying delivery system in high-fat diet induced hyperlipidemic mice: Formulation, in vitro and in vivo evaluation. Eur J Pharm Sci 2016;85:112-22. [PMID: 26851382 DOI: 10.1016/j.ejps.2016.02.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
16 Owen A, Rannard S. Considerations for clinically-relevant nanomedicine therapies for chronic diseases. Nanomedicine (Lond) 2015;10:3103-7. [PMID: 26446297 DOI: 10.2217/nnm.15.135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
17 Dlugaszewska J, Dobrucka R. Effectiveness of Biosynthesized Trimetallic Au/Pt/Ag Nanoparticles on Planktonic and Biofilm Enterococcus faecalis and Enterococcus faecium Forms. J Clust Sci 2019;30:1091-101. [DOI: 10.1007/s10876-019-01570-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
18 Chai G, Meng Y, Chen S, Hu F, Gan Y, Yuan H. Transport features and structural optimization of solid lipid nanoparticles crossing the intestinal epithelium. RSC Adv 2016;6:70433-45. [DOI: 10.1039/c6ra12978a] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Lakkireddy HR, Urmann M, Besenius M, Werner U, Haack T, Brun P, Alié J, Illel B, Hortala L, Vogel R, Bazile D. Oral delivery of diabetes peptides - Comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context. Adv Drug Deliv Rev 2016;106:196-222. [PMID: 26964477 DOI: 10.1016/j.addr.2016.02.011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
20 Hinkley GK, Roberts SM. Factors Affecting the Oral Bioavailability of Nanomaterials. In: Sahu SC, Casciano DA, editors. Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology. Chichester: John Wiley & Sons, Ltd; 2014. pp. 147-60. [DOI: 10.1002/9781118856017.ch9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 de Oliveira MTP, Coutinho DS, Guterres SS, Pohlmann AR, Silva PMRE, Martins MA, Bernardi A. Resveratrol-Loaded Lipid-Core Nanocapsules Modulate Acute Lung Inflammation and Oxidative Imbalance Induced by LPS in Mice. Pharmaceutics 2021;13:683. [PMID: 34068619 DOI: 10.3390/pharmaceutics13050683] [Reference Citation Analysis]
22 Khalifa MKA, Salem HA, Shawky SM, Eassa HA, Elaidy AM. Enhancement of zaleplon oral bioavailability using optimized self-nano emulsifying drug delivery systems and its effect on sleep quality among a sample of psychiatric patients. Drug Deliv 2019;26:1243-53. [PMID: 31752566 DOI: 10.1080/10717544.2019.1687613] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
23 Trevaskis NL, Kaminskas LM, Porter CJH. From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity. Nat Rev Drug Discov 2015;14:781-803. [DOI: 10.1038/nrd4608] [Cited by in Crossref: 279] [Cited by in F6Publishing: 266] [Article Influence: 39.9] [Reference Citation Analysis]
24 Chai GH, Xu Y, Chen SQ, Cheng B, Hu FQ, You J, Du YZ, Yuan H. Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and their Related Cytotoxicology. ACS Appl Mater Interfaces 2016;8:5929-40. [PMID: 26860241 DOI: 10.1021/acsami.6b00821] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 10.8] [Reference Citation Analysis]
25 Hunter AC, Moghimi SM. Smart polymers in drug delivery: a biological perspective. Polym Chem 2017;8:41-51. [DOI: 10.1039/c6py00676k] [Cited by in Crossref: 41] [Article Influence: 8.2] [Reference Citation Analysis]
26 Carbone C, Leonardi A, Cupri S, Puglisi G, Pignatello R. Pharmaceutical and biomedical applications of lipid-based nanocarriers. Pharm Pat Anal 2014;3:199-215. [PMID: 24588596 DOI: 10.4155/ppa.13.79] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
27 Liu J, Cao J, Cao J, Han S, Liang Y, Bai M, Sun Y. Mechanistic insight into the interaction of gastrointestinal mucus with oral diblock copolymers synthesized via ATRP method. Int J Nanomedicine 2018;13:2839-56. [PMID: 29805260 DOI: 10.2147/IJN.S160651] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
28 Hernandez FJ, Hernandez LI, Kavruk M, Arıca YM, Bayramoğlu G, Borsa BA, Öktem HA, Schäfer T, Özalp VC. NanoKeepers: stimuli responsive nanocapsules for programmed specific targeting and drug delivery. Chem Commun (Camb) 2014;50:9489-92. [PMID: 25008577 DOI: 10.1039/c4cc04248d] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
29 Sonam, Chaudhary H, Arora V, Kholi K, Kumar V. Effect of Physicochemical Properties of Biodegradable Polymers on Nano Drug Delivery. Polymer Reviews 2013;53:546-67. [DOI: 10.1080/15583724.2013.828751] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
30 Balusamy B, Celebioglu A, Senthamizhan A, Uyar T. Progress in the design and development of "fast-dissolving" electrospun nanofibers based drug delivery systems - A systematic review. J Control Release 2020;326:482-509. [PMID: 32721525 DOI: 10.1016/j.jconrel.2020.07.038] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
31 Moghimi SM. Nanoparticle patterning for biomedicine. Bioimpacts 2016;6:183-5. [PMID: 28265533 DOI: 10.15171/bi.2016.24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
32 Severino P, da Silva CF, Andrade LN, de Lima Oliveira D, Campos J, Souto EB. Alginate Nanoparticles for Drug Delivery and Targeting. Curr Pharm Des 2019;25:1312-34. [PMID: 31465282 DOI: 10.2174/1381612825666190425163424] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 25.0] [Reference Citation Analysis]
33 Fox CB, Chirra HD, Desai TA. Planar bioadhesive microdevices: a new technology for oral drug delivery. Curr Pharm Biotechnol 2014;15:673-83. [PMID: 25219863 DOI: 10.2174/1389201015666140915152706] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
34 Tong T, Wang L, You X, Wu J. Nano and microscale delivery platforms for enhanced oral peptide/protein bioavailability. Biomater Sci 2020;8:5804-23. [PMID: 33016274 DOI: 10.1039/d0bm01151g] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
35 Stagnoli S, Luna MA, Villa CC, Alustiza F, Niebylski A, Moyano F, Correa NM, Falcone RD. Unique catanionic vesicles as a potential “Nano-Taxi” for drug delivery systems. In vitro and in vivo biocompatibility evaluation. RSC Adv 2017;7:5372-80. [DOI: 10.1039/c6ra27020d] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
36 Mokhtar M, Gosselin P, Lacasse F, Hildgen P. Design of PEG-grafted-PLA nanoparticles as oral permeability enhancer for P-gp substrate drug model Famotidine. J Microencapsul 2017;34:91-103. [PMID: 28151040 DOI: 10.1080/02652048.2017.1290155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
37 Jadhav S, Yenorkar N, Bondre R, Karemore M, Bali N. Nanomedicines encountering HIV dementia: A guiding star for neurotherapeutics. Journal of Drug Delivery Science and Technology 2022;71:103315. [DOI: 10.1016/j.jddst.2022.103315] [Reference Citation Analysis]
38 Chen SQ, Song YQ, Wang C, Tao S, Yu FY, Lou HY, Hu FQ, Yuan H. Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis. Carbohydr Polym 2020;230:115613. [PMID: 31887935 DOI: 10.1016/j.carbpol.2019.115613] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
39 Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art. J Control Release 2016;240:504-26. [PMID: 27292178 DOI: 10.1016/j.jconrel.2016.06.016] [Cited by in Crossref: 184] [Cited by in F6Publishing: 154] [Article Influence: 30.7] [Reference Citation Analysis]
40 Maisel K, Ensign L, Reddy M, Cone R, Hanes J. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. J Control Release. 2015;197:48-57. [PMID: 25449804 DOI: 10.1016/j.jconrel.2014.10.026] [Cited by in Crossref: 193] [Cited by in F6Publishing: 179] [Article Influence: 24.1] [Reference Citation Analysis]
41 Liu J, Leng P, Liu Y. Oral drug delivery with nanoparticles into the gastrointestinal mucosa. Fundam Clin Pharmacol 2021;35:86-96. [PMID: 32749731 DOI: 10.1111/fcp.12594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Đorđević V, Belščak-cvitanović A, Drvenica I, Komes D, Nedović V, Bugarski B. Nanoscale nutrient delivery systems. Nutrient Delivery. Elsevier; 2017. pp. 87-139. [DOI: 10.1016/b978-0-12-804304-2.00003-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
43 Rehman FU, Shah KU, Shah SU, Khan IU, Khan GM, Khan A. From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS). Expert Opinion on Drug Delivery 2016;14:1325-40. [DOI: 10.1080/17425247.2016.1218462] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
44 Span K, Verhoef JJF, Hunt H, van Nostrum CF, Brinks V, Schellekens H, Hennink WE. A novel oral iron-complex formulation: Encapsulation of hemin in polymeric micelles and its in vitro absorption. Eur J Pharm Biopharm 2016;108:226-34. [PMID: 27600943 DOI: 10.1016/j.ejpb.2016.09.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
45 Jafari SM, Katouzian I, Akhavan S. Safety and regulatory issues of nanocapsules. Nanoencapsulation Technologies for the Food and Nutraceutical Industries. Elsevier; 2017. pp. 545-90. [DOI: 10.1016/b978-0-12-809436-5.00015-x] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
46 Englert C, Brendel JC, Majdanski TC, Yildirim T, Schubert S, Gottschaldt M, Windhab N, Schubert US. Pharmapolymers in the 21st century: Synthetic polymers in drug delivery applications. Progress in Polymer Science 2018;87:107-64. [DOI: 10.1016/j.progpolymsci.2018.07.005] [Cited by in Crossref: 73] [Cited by in F6Publishing: 26] [Article Influence: 18.3] [Reference Citation Analysis]
47 Fox CB, Kim J, Le LV, Nemeth CL, Chirra HD, Desai TA. Micro/nanofabricated platforms for oral drug delivery. J Control Release 2015;219:431-44. [PMID: 26244713 DOI: 10.1016/j.jconrel.2015.07.033] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 9.3] [Reference Citation Analysis]
48 Lin C, Chen C, Lin Z, Fang J. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers. Journal of Food and Drug Analysis 2017;25:219-34. [DOI: 10.1016/j.jfda.2017.02.001] [Cited by in Crossref: 129] [Cited by in F6Publishing: 98] [Article Influence: 25.8] [Reference Citation Analysis]
49 Iglesias T, López de Cerain A, Irache J, Martín-arbella N, Wilcox M, Pearson J, Azqueta A. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery. International Journal of Pharmaceutics 2017;517:67-79. [DOI: 10.1016/j.ijpharm.2016.11.059] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
50 Fonte P, Araújo F, Silva C, Pereira C, Reis S, Santos HA, Sarmento B. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches. Biotechnol Adv 2015;33:1342-54. [PMID: 25728065 DOI: 10.1016/j.biotechadv.2015.02.010] [Cited by in Crossref: 124] [Cited by in F6Publishing: 106] [Article Influence: 17.7] [Reference Citation Analysis]
51 Ganugula R, Arora M, Saini P, Guada M, Kumar MNVR. Next Generation Precision-Polyesters Enabling Optimization of Ligand-Receptor Stoichiometry for Modular Drug Delivery. J Am Chem Soc 2017;139:7203-16. [PMID: 28395139 DOI: 10.1021/jacs.6b13231] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
52 Ammar HO, Ghorab M, Kamel R, Salama AH. A trial for the design and optimization of pH-sensitive microparticles for intestinal delivery of cinnarizine. Drug Deliv and Transl Res 2016;6:195-209. [DOI: 10.1007/s13346-015-0277-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
53 Chai G, Hu F, Sun J, Du Y, You J, Yuan H. Transport Pathways of Solid Lipid Nanoparticles Across Madin–Darby Canine Kidney Epithelial Cell Monolayer. Mol Pharmaceutics 2014;11:3716-26. [DOI: 10.1021/mp5004674] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
54 Brenner JS, Mitragotri S, Muzykantov VR. Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers. Annu Rev Biomed Eng 2021;23:225-48. [PMID: 33788581 DOI: 10.1146/annurev-bioeng-121219-024239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Tatham LM, Rannard SP, Owen A. Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics. Ther Deliv 2015;6:469-90. [PMID: 25996045 DOI: 10.4155/tde.15.4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
56 Bag J, Mukherjee S, Tripathy M, Mohanty R, Shendha PK, Hota G, Mishra M. Platinum as a Novel Nanoparticle for Wound Healing Model in Drosophila melanogaster. J Clust Sci. [DOI: 10.1007/s10876-022-02292-9] [Reference Citation Analysis]
57 Wilkhu JS, Mcneil SE, Anderson DE, Perrie Y. Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines. Drug Deliv and Transl Res 2014;4:233-45. [DOI: 10.1007/s13346-013-0174-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
58 Moghimi SM, Farhangrazi ZS. Nanoparticles in Medicine. Nanoparticles and the Immune System. Elsevier; 2014. pp. 77-89. [DOI: 10.1016/b978-0-12-408085-0.00006-6] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]